- Home
- CCRN vs CGEN Comparison
CCRN vs CGEN Comparison
Compare CCRN & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCRN | CGEN |
|---|---|---|
| Founded | 1986 | 1993 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 315.1M | 270.4M |
| IPO Year | 2001 | 2001 |
Fundamental Metrics
Financial Performance| Metric | CCRN | CGEN |
|---|---|---|
| Price | $13.06 | $2.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $14.15 | $5.00 |
| AVG Volume (30 Days) | ★ 928.9K | 577.7K |
| Earning Date | 05-07-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $816,484,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.01 | $75.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.43 | $1.30 |
| 52 Week High | $14.98 | $3.24 |
Technical Indicators
Market Signals| Indicator | CCRN | CGEN |
|---|---|---|
| Relative Strength Index (RSI) | 75.68 | 53.25 |
| Support Level | $11.69 | $1.46 |
| Resistance Level | $13.31 | $3.14 |
| Average True Range (ATR) | 0.13 | 0.18 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 95.83 | 54.37 |
Price Performance
Historical ComparisonAbout CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.